Shakespeare Wealth Management’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDN
CAI
ACA
AWM
CIM
Shakespeare Wealth Management's IBDN Position: Q1 2020 in Review
Shakespeare Wealth Management sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q1 2020, closing a stake of 16,702 shares — an estimated $422K sold.
Shakespeare Wealth Management first reported a position in IBDN in Q2 2019 and held it in 3 quarters. The position peaked at $422K in Q4 2019. 172 funds tracked by Wall St. Rank hold IBDN as of Q1 2020.
- Shakespeare Wealth Management reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q1 2020 after selling out during the quarter.
- Shakespeare Wealth Management sold 16,702 iShares iBonds Dec 2022 Term Corporate ETF shares in Q1 2020, an estimated $422K.
- Shakespeare Wealth Management first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q2 2019 and held it in 3 quarters.
- Shakespeare Wealth Management's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $422K in Q4 2019.
- 172 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q1 2020.
Based on Shakespeare Wealth Management's 13F filing for Q1 2020, filed 1 Apr 2020.